Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10908911 | Leukemia Research | 2013 | 7 Pages |
Abstract
The expression of activated forms of key proteins of the DNA damage response machinery (pNBS1, pATM and γH2AX) was assessed by means of immunohistochemistry in bone marrow biopsies of 74 patients with de novo myelodysplastic syndromes (MDS) and compared with 15 cases of de novo acute myeloid leukemia (AML) and 20 with reactive bone marrow histology. Expression levels were significantly increased in both MDS and AML, compared to controls, being higher in high-risk than in low-risk MDS. Increased pNBS1 and γH2AX expression possessed a significant negative prognostic impact for overall survival in MDS patients, whereas pNBS1 was an independent marker of poor prognosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maria Kefala, Sotirios G. Papageorgiou, Christos K. Kontos, Panagiota Economopoulou, Athanasios Tsanas, Vasiliki Pappa, Ioannis G. Panayiotides, Vassilios G. Gorgoulis, Eustratios Patsouris, Periklis G. Foukas,